Effects of small peptides or amino acids infused to a perfused area of the skin of Angora goats on mohair growth

The effect of infusing dipeptides or their amino acids on mohair growth of Angora goats was investigated using a skin perfusion technique. Seven Angora wethers (average BW 24 +/- 2.5 kg) were implanted bilaterally with silicon catheters into the superficial branches of the deep circumflex iliac artery and vein and carotid artery. The experiment consisted of three 28-d phases. In the first 14 d of Phases 1 and 3, saline was infused into deep circumflex iliac arteries supplying skin and in Phase 2 a mixture of dipeptides (methionine-leucine [Met-Leu], lysine-leucine [Lys-Leu]) was infused into the artery on one side, and free amino acids were administered on the other side. Infusion rates of peptides were 0.85 mg/h Met-Leu and 0.85 mg/h Lys-Leu in 2.4 mL saline. Infusion rates of amino acids were 0.474 mg/h Lys, 0.483 mg/h Met, and 0.743 mg/h Leu in 2.4 mL saline. A 100-cm2 area within the perfused region was used to determine mohair growth. Two weeks after the cessation of infusions, perfused areas were shorn. Clean mohair production from the dipeptide- and amino acids-perfused regions were similar (4.21 vs 4.35 g/[100 cm2 +/- 28 d], respectively; P > 0.05). However, clean mohair production during dipeptides and amino acids infusions was greater (P < 0.01) than that observed during saline infusions (3.63 g/[100 cm2 +/- 28 d]). There were no significant differences between dipeptides and free amino acids in concentrations of various hormones and metabolites in blood from deep circumflex iliac veins (P > 0.05). In conclusion, the studied small dipeptides and amino acids similarly increased mohair fiber growth, presumably through supplying limiting amino acids directly to the fiber follicle.     

Chronic arterial cannulation for studying the skin of sheep

Cutaneous branches of intercostal, external thoracic and deep circumflex iliac arteries in a total of 77 sheep were cannulated using one of two methods described. These cutaneous preparations, supplying areas of wool-growing skin from 30 to 400 cm2, remained patent for up to six weeks as determined by dye infusion. Wool was readily plucked by hand from preparations infused with either 12 mg betamethasone for eight days or 1.2 g mimosine for two days thereby demonstrating that normal defleecing responses can be elicited in animals bearing isolated cutaneous preparations.     

Effect of intraperitoneal administration of lysine and methionine on mohair yield and quality in Angora goats.

Eight mature Angora wethers (average BW 47.2 kg) were used in a 4 x 4 replicated Latin square design to evaluate responses to intraperitoneal (IP) administration of amino acids. The IP treatments consisted of saline (Control), methionine 1 g/d (Met), lysine 2 g/d (Lys), and methionine + lysine (Met + Lys). The amino acids dissolved in Control were infused continuously for the first 14 d of each 28-d period using peristaltic infusion pumps. Average d-28 grease and clean mohair yields (grams/100 square centimeters), and fiber diameter (micrometers) and length (centimeters) measurements during Control administration were 8.8, 7.6, 40, and 2.3, respectively. Mean clean mohair yield and fiber diameter increased by 5.3% (P less than .039) and 2.5% (P less than .067), respectively, with Met administration but were decreased by 9.2% (P less than .033) and 3.8% (P less than .001), respectively, by Lys administration; however, mean fiber length was increased (P less than .014) 21.7% by Lys infusion. The goats did not exhibit increased grease (P greater than .939) and clean (P greater than .477) mohair yields and fiber diameter (P greater than .619) when treated with Met+Lys. A N balance trial was conducted during d 10 through 14 of each period. Total retained N (grams per day) during Control administration was 18.4 and 24% greater than Met (P greater than .281) and Lys (P less than .061), respectively. When expressed as a proportion of N intake, retained N was lowest (P less than .127) in the Lys infusion group. Jugular blood ammonia N and plasma glucose and total protein concentrations were not affected (P greater than .10) by treatment.(ABSTRACT TRUNCATED AT 250 WORDS)     

真胃灌注缺失精氨酸、苏氨酸或组氨酸的混合氨基酸对泌乳山羊乳腺氨基酸代谢的影响

本试验旨在研究真胃灌注缺失精氨酸(Arg)、苏氨酸(Thr)或组氨酸(His)的混合氨基酸对泌乳山羊乳腺氨基酸代谢的影响。选择4只泌乳中期萨能奶山羊,安装真胃插管(用于灌注氨基酸)、颈动脉和乳静脉血管插管(用于采集血样),在外阴动脉安装血液流量计探头(记录乳腺血流量)。试验羊限饲基础饲粮,满足维持能量和蛋白质需要。真胃灌注葡萄糖和按瘤胃微生物蛋白氨基酸构成配制的混合氨基酸。采用4×4拉丁方试验设计,对照组灌注全混合氨基酸,试验组分别灌注缺失Arg、Thr、His的混合氨基酸;试验共进行4期,每期7 d,前4天为灌注期,后3天为采样期。结果表明:1)单一氨基酸缺失灌注对产奶量和乳蛋白产量均无显著影响(P0.05)。2)Arg和Thr缺失显著提高了乳腺血流量(P≤0.05),降低了该氨基酸的动脉浓度、静脉浓度,乳腺清除率分别上升25.9%和199.2%;单一氨基酸缺失灌注对该氨基酸乳腺吸收量和乳腺吸收产出比无显著影响(P0.05)。3)Arg、Thr和His缺失,泌乳转化效率分别提高25.4%(4.02 vs.5.04,P≤0.05)、34.5%(9.09 vs.12.23,P≤0.05)和14.6%(10.51 vs.12.04,0.05P≤0.10)。结果提示,泌乳山羊通过提高乳腺血流量和乳腺清除率增加了饲粮对乳腺缺失氨基酸的供给,从而提高了缺失氨基酸的泌乳转化效率。     

Effects of exogenous ghrelin on feed intake, weight gain, behavior, and endocrine responses in weanling pigs

The objectives were to determine relative ADG, ADFI, behavior, and endocrine responses in weaned pigs receiving exogenous ghrelin. Twenty-four barrows weaned at 18 d of age (d 0 of the experiment) were catheterized via the jugular vein, weighed, and assigned to either a ghrelin (n = 12) or saline (control; n = 12) infusion group. Initial pig BW did not differ between treatments (7.87+/-0.39 vs. 7.92+/-0.35 kg for ghrelin and control treatments, respectively). Pig BW and feed intakes were measured once daily throughout the experiment. Starting on d 1, the ghrelin pigs were intravenously infused three times daily for 5 d with 2 microg/kg BW of human ghrelin, and the control pigs were similarly infused with saline. Activity observations and blood samples were taken at -15, 0, 15, 30, 60, 90, 120, 240, and 480 min relative to the first infusion and then three times daily (0800, 1600, and 2400) for 8 d. Weight gain during the 5-d infusion period was greater by the ghrelin than by control pigs (0.57+/-0.10 vs. 0.21+/-0.13 kg, respectively; P < 0.04); however, there was no increase in feed intake. During two behavioral observation periods, more pigs in the ghrelin treatment were observed eating compared with control pigs (P < 0.05). The initial infusion of exogenous ghrelin increased serum ghrelin, GH, insulin, and cortisol concentrations (P < 0.05). Endogenous serum ghrelin increased from d 1 to 8 of the experiment in control animals (P < 0.05). Serum IGF-I initially fell in both treatment groups from d 1 to 2 (P < 0.05) but then increased from d 5 to 8 (P < 0.05). Peripheral concentrations of glucose in the ghrelin pigs were greater on d 2, 3, 7, and 8 than on d 1 (P < or = 0.05). In both treatment groups, peripheral concentrations of leptin increased from d 7 to 8, and cortisol decreased from d 1 to 5 of the experiment. These observations provide evidence that ghrelin may positively influence weight gain and concomitantly increase GH, insulin, and cortisol secretion in weaned pigs.     

Effects of isoenergetic infusions of propionate and glucose on portal-drained visceral nutrient flux and concentrations of hormones in lambs maintained by total intragastric infusion

Three lambs were used in a repeated Latin square design to determine the influence of isoenergetic infusions of propionate or glucose on portal-drained visceral flux (PDV) of nutrients and concentrations of insulin, glucagon, growth hormone and prolactin. Lambs were fitted with appropriate catheters for blood sampling and maintained on total intragastric infusion of nutrients. Basal VFA, casein, mineral and vitamin infusions (isocaloric and isonitrogenous) were supplemented with an additional 22 +/- .5 kcal/h from propionate, glucose or a combination of propionate plus glucose. Ruminal fluid proportion and arterial blood concentration and PDV flux of propionate increased (P less than .10) by 17 mol/100 mol, .02 mM and 40 mmol/h, respectively, with infusion of an additional 61 mmol/h of propionate. Regression equations predicted that, on a net basis, 67% of ruminally infused propionate and 43% of abomasally infused glucose appeared in portal blood. Arterial L-lactate, beta-hydroxybutyrate and acetate concentrations, and beta-hydroxybutyrate flux were increased (P less than .10) by .34 mM, .20 mM, .50 mM and 4.2 mmol/h, respectively, with infusion of 33 mmol/h of added glucose. Net utilization of glucose by the PDV was approximately 4.4 mmol/h when no glucose was infused. Increased infusion of propionate resulted in a 22.2-micrograms/h increase in PDV flux of insulin (P less than .08) but had no effect on arterial insulin, glucagon and prolactin concentrations (P greater than .10). Arterial growth hormone increased by 3.8 ng/ml with increasing glucose infusion (P less than .08).(ABSTRACT TRUNCATED AT 250 WORDS)     

Inhibition of endogenous nitric oxide production influences ovine hindlimb metabolism independently of insulin concentrations

The hindlimb arteriovenous difference (AVD) model was used to determine whether 30 mg/ kg of the nitric oxide synthase (NOS) inhibitor L-NGnitroarginine methyl ester (hydrochloride; L-NAME) inhibited ovine NO synthesis and influenced muscle metabolism. Eight Border Leicester x Merino cross lambs (50 to 55 kg BW) were infused with saline (control) or saline containing L-NAME via an indwelling jugular vein catheter in a balanced randomized crossover design with 3 d between treatments. The abdominal aorta and deep femoral vein were catheterized for assessment of AVD of hind limb metabolism. Arterial hematocrit and insulin concentration and both arterial and venous concentrations of nitrate/nitrite (NOx), glucose, lactate, NEFA, and urea were determined. Infusion of L-NAME decreased arterial NOx concentrations (P = 0.049), indicating inhibition of systemic NO synthesis. Treatment had no effect on arterial (3.5 vs. 3.6 +/- 0.19 mmol/L for control and L-NAME lambs, respectively; P = 0.39) or venous (3.3 vs. 3.4 +/- 0.16 mmol/L, P = 0.55) plasma glucose concentrations or on glucose AVD (0.19 vs. 0.27 +/- 0.065 mmol/L, P = 0.20). There was an interaction (P = 0.038) between time and treatment, such that L-NAME initially increased the AVD of glucose (up to 180 m) divergent from control lambs. The response was then decreased before a possible inflection beyond 240 min. Infusion of L-NAME increased hindlimb venous NEFA (222 vs. 272 +/- 13.2 micromol/L, P = 0.007) and NEFA AVD (79.4 vs. -13.3 +/- 31.5 micromol/L, P = 0.018). These metabolic changes were independent of plasma insulin concentrations, which were not affected by L-NAME infusion (25.3 vs. 27.8 +/- 3.62 mU/L, P = 0.85). The increase in hindlimb lipolysis after L-NAME infusion does not seem to be due to increased lipolysis of plasma triacylglycerol because circulating arterial (155 vs. 142 +/- 20.8 micromol/L, P = 0.58), venous (154 vs. 140 +/- 20.5 micromol/L, P = 0.50), and AVD (1.0 vs. 2.9 +/- 3.17 micromol/L, P = 0.38) triacylglycerol concentrations were unaffected by L-NAME infusion. In conclusion, these data indicate that infusion of 30 mg of L-NAME/kg inhibits NO synthesis, which in turn influences fat and carbohydrate metabolism in the ovine hindlimb independently of plasma insulin concentrations.     

Effects of thyrotropin-releasing hormone and a thyrotropin releasing hormone analog on growth and selected plasma hormones in lambs

An 8-wk growth trial was conducted to assess the effects of continuous infusion of thyrotropin-releasing hormone (TRH) and an active TRH analog less than Aad-His-Pro-NH2 (the less than Aad is L-pyro-alpha-aminoadipic acid) on growth trial performance, carcass composition and hormone profiles of growing lambs. Both drugs were infused at 600 micrograms X lamb -1 X d -1 with 16 lambs/treatment. Both TRH and less than Aad-His-Pro-NH2 decreased average daily gain (ADG; P less than .01) and increased feed conversion (FC; P less than .01) compared with saline infused controls. Average daily feed intake was not altered. Carcasses of lambs given TRH or less than Aad-His-Pro-NH2 contained fewer kilograms of moisture (P less than .05) and appeared to contain fewer kilograms of protein. Thyrotropin-releasing hormone and less than Aad-His-Pro-NH2 increased thyroid gland weights (P less than .05), but pituitary gland weights were not different. Plasma thyrotropin (TSH) concentrations were increased by both drugs compared with control lambs, peaking at 4 to 7 d after initiating infusion. However, by 14 d, TSH concentrations returned to control levels. Triiodothyronine (T3) and thyroxine (T4) were elevated by both drugs over the entire 8-wk trial, with peak levels reached at 10 d and maintained for the duration of the study. Both TRH and less than Aad-His-Pro-NH2 increased prolactin over the entire period. Growth hormone levels were not altered by either drug. The effects of less than Aad-His-Pro-NH2 infusion on growth trial performance, carcass composition and hormone profiles of growing lambs were very similar to TRH. The negative effects of TRH and less than Aad-His-Pro-NH2 infusion on ADG, FC and carcass protein appear to be the result of elevated T3 and T4 levels.     

Effects of mimosine on fiber shedding, follicle activity, and fiber regrowth in Spanish goats

Ten 2-yr-old Spanish wethers (58.2 +/- 7.21 kg BW) were used to determine effects of 2-d intravenous infusion of mimosine (beginning on January 8) on fiber shedding, follicle activity, and fiber regrowth. Primary and secondary follicle activity on d 0 were 43 +/- 6.2% and 96 +/- 1.7%, respectively. Five wethers were infused with mimosine at 120 mg/(kg BW x d) and the other five received saline. At 7 to 10 d after the start of infusion, all five goats infused with mimosine exhibited shedding, whereas shedding by controls was not observed. Cashmere fiber shedding score (5-point scale: 1 = no shedding, 5 = excessive shedding) on d 4 was greater for mimosine goats than for controls (1.2 vs 2.0; P < .001), and shedding score for wethers receiving mimosine was greater (P < .05) on d 12, 16, and 20 than on d 0 and 4 (4.1 to 4.6 vs 1.4 and 2.0). Guard hair shedding score for goats receiving mimosine was greatest (P < .01) among the days after infusion for d 12 and greater (P < .01) on d 16 than on d 0 and 4. Nonetheless, cashmere fiber yield from combed fleece of mimosine goats (average of 73%) was much greater than for a clipping of the uncombed side (average of 28%) when the cashmere fiber shedding score exceeded 4.0. Secondary follicle activity on d 12 was lower (P < .01) for mimosine than for control wethers (6.8 vs 67.7%), and secondary follicle activity for mimosine-infused goats on d 12 was lower (P < .01) than on d 0 (98.9%), 4 (98.3%), and 20 (99.5%). Mimosine infusion resulted in no detectable fiber regrowth in wk 4 to 7 after the start of infusion, but regrowth rate in the following two 4-wk periods was similar for mimosine and control wethers. In conclusion, 2-d intravenous infusion of mimosine at 120 mg/(kg BW x d) in the winter induced cashmere shedding but had less effect on guard hairs, suggesting future potential use of chemicals such as mimosine to remove cashmere fiber.     

Effect of growth hormone-releasing factor infusion on somatotropin, prolactin, thyroxine, insulin, insulin-like growth factor I and blood metabolites in control and somatostatin-immunized growing pigs.

The aim of this study was to characterize the effects of prolonged infusion of growth hormone-releasing factor (1-29)NH2 (GRF) on plasma concentrations of hormones and metabolites when administered to control pigs and pigs immunized against somatostatin (SRIF). In the first experiment, eight purebred Yorkshire boars averaging 113 +/- 2 kg BW were immunized against SRIF conjugated to bovine serum albumin (BSA) (n = 4) or BSA alone (n = 4). Somatotropin (ST) response to four rates of GRF infusion (0, 1.66, 5 and 15 ng/min/kg BW) for 6 hr was evaluated using a double balanced 4 x 4 Latin square design. During the 4 hr before infusion, SRIF-immunized animals tended (P = 0.06) to have a higher ST release (613 vs 316 ng.min/ml, SE = 232) than controls. During infusion, GRF elicited a dose-dependent increase in ST release in both squares; the ST response was not better in SRIF-immunized animals than in controls (P greater than 0.05) (1435 vs 880 ng.min/ml; SE = 597). In the second experiment, ten purebred Yorkshire boars (5 controls and 5 SRIF-immunized animals) averaging 69 +/- 2 kg BW were continuously infused with GRF at the rate of 15 ng/min/kg BW for six consecutive d. Under GRF infusion, ST concentrations increased (P less than 0.05) from 805 to 4768 ng.min/ml (SE = 507) from day 1 to day 6 in both SRIF-immunized and control animals. Prolactin levels increased (P less than 0.05) with GRF infusion; pattern of increase was different (P less than .01) overtime in control and SRIF-immunized animals. Thyroxine levels increased from 2.53 to 3.45 micrograms/dl (SE = 0.16) after six d of infusion. Insulin-like growth factor I was higher (P less than 0.05) before (139 vs 90 ng/ml; SE = 11) and during (222 vs 185 ng/ml; SE = 11) GRF infusion in SRIF-immunized animals. A transient increase (P less than 0.05) in glucose and insulin was observed in both groups. Immunization against SRIF had no effect on blood metabolites; however, GRF infusion increased free fatty acids from 157 to 204 microEq/l (SE = 11) and decreased blood urea nitrogen from 4.1 to 3.5 mmol/l (SE = 0.2) from day 1 to day 6, respectively. In summary, active immunization against SRIF in growing pigs increased ST and IGF-I concentrations. Infusion of GRF continuously raised ST levels with days of infusion without any sign of decrease responsiveness.     

Growth performance and carcass composition of lambs infused for 28 days with a growth hormone-releasing factor analogue.

A human growth hormone-releasing factor analogue, [DesNH2Tyr1,D-Ala2,Ala15]hGRF(1-29)NH2 (GRF-A), was infused s.c. into lambs for 28 d to determine its effects on growth performance and carcass composition. Twenty crossbred wethers weighing 47.0 +/- .5 kg were implanted with 7-d osmotic minipumps at weekly intervals. Minipumps contained either vehicle (dimethyl sulfoxide:H2O, 1:1) or GRF-A, released at a rate of 208 pmol (or .7 micrograms).h-1.kg-1. During the infusion period, plasma GH levels were increased (P less than .01) in GRF-A-treated wethers compared with control wethers (15.0 vs 9.3 ng/ml) and were higher on days that closely followed minipump implantation. Plasma IGF-I and hepatic IGF-I RNA concentrations were similar in lambs of both groups. Analogue treatment improved feed conversion (4.9 vs 5.8 kg dry matter/kg gain, P less than .05), increased average daily gain (.35 vs .30 kg, P = .05) and had no effect on feed intake, wool growth and body, carcass, selected organ and pituitary weights. Carcasses from GRF-A-infused lambs had less adjusted fat depth, a lower percentage of fat and a higher percentage of protein (P less than .05) than carcasses from control lambs. Magnitude of most effects of GRF-A on carcass measurements were correlated with the mean GH level that a lamb had during the infusion period. In conclusion, s.c. infusion of GRF-A improved feed utilization and altered carcass composition of feeder lambs in a relatively short period of time (28 d).     

Portal-drained visceral flux of nutrients in lambs fed alfalfa or maintained by total intragastric infusion

An experiment was performed using lambs fitted with chronic indwelling catheters in appropriate blood vessels for portal-drained visceral (PDV) flux measurements. The objective of the experiment was to evaluate PDV nutrient flux in alfalfa-fed and intragastrically infused lambs and to evaluate the effects of amount of energy and N infused on PDV nutrient metabolism. Lambs were fed alfalfa or infused with 1.64 and 10.9; 1.82 and 12.3; or 2.37 and 15.0 Mcal GE and g N/d, respectively. Arterial concentrations and PDV fluxes of glucose, L-lactate, acetate and portal blood flow were not different (P greater than .10) between alfalfa-fed and infused lambs. Net flux of alpha-amino N, ammonia N and branched-chain VFA were lower (P less than .05) and net flux of propionate, butyrate and total VFA were higher for intragastric infusion vs alfalfa. No consistent differences in PDV fluxes were noted among the three levels of energy and N infused, although the energy and N levels tested were near maintenance requirements. Nitrogen retention increased as level of energy and N infusion increased. Approximately 47, 70 and 22% of ruminally infused acetate, propionate and butyrate, respectively, were found on a net basis in portal blood as VFA. Measurements of net nutrient utilization by the PDV that eliminate the influence of ruminal fermentation are possible. How the changes in PDV tissues due to intragastric infusion influence these estimates is unknown.     

Myoperitoneal Microvascular Free Flaps in Dogs: An Anatomical Study and a Clinical Case Report

The purpose of the anatomical study was to identify potential myoperitoneal microvascular free flaps, in dogs, that are based on a single artery and vein. The angiosomes of the right deep circumflex iliac artery and left phrenicoabdominal (cranial abdominal) artery were evaluated in six medium-sized canine cadavers. The right deep circumflex iliac artery and left phrenicoabdominal (cranial abdominal) artery were injected with a mixture of barium and latex (equal parts). The entire right and left transversus abdominis muscles were dissected from the abdominal wall and radiographed. The angiograms of the deep circumflex iliac artery showed poor arborization of the vessels within the transversus abdominis muscle in all six cadavers. The angiograms of the phrenicoabdominal (cranial abdominal) artery showed consistent filling of the vascular bed of the cranial half of the transversus abdominis muscle flap in all six dogs. The vascular pedicle lengths and the diameter of the arteries and veins of both the deep circumflex iliac and phrenicoabdominal (cranial abdominal) myoperitoneal free flaps were found to be acceptable for microvascular anastomosis. The deep circumflex iliac flap was unacceptable because of inadequate vascular perfusion. The cranial abdominal artery had a consistent, large branch that supplied the cranial half of the transversus abdominis muscle, thereby making a myoperitoneal flap supplied by this vessel a potentially useful free flap. An 8-year-old male, neutered, mixed-breed dog was evaluated for possible repair of a large defect of the hard palate. Previous operations, using local tissue flaps, had been unsuccessful. A myoperitoneal free flap, based on the right cranial abdominal artery, and consisting of the cranial portion of the transversus abdominis muscle, was used successfully to reconstruct the hard palate. Migrating epithelium from the edges of the wound covered the myoperitoneal flap by 10 weeks after surgery. Therefore, the cranial abdominal myoperitoneal free flap can be considered for reconstruction of intra-oral defects that cannot be repaired using conventional local flap techniques.     

Effects of bovine somatotropin and ruminally undegraded protein on feed intake, live weight gain, and mohair production by yearling Angora wethers.

Yearling Angora wethers (n = 24; 24+/-1.0 kg BW) were used in an experiment with a 2 x 2 factorial arrangement of treatments to investigate effects of bovine somatotropin (bST) treatment and dietary level of ruminally undegraded protein on DMI, ADG, and mohair production. Untreated casein (UC) or casein treated with formaldehyde (TC) was included at 7% DM of a diet containing 11% CP and 46% concentrate. A slow-release bST form was administered weekly to deliver 0 (Control) or 100 microg/ (kg BW.d) of bST. Plasma concentrations of bST and IGF-I were increased (P < .05) during the 7-d period following bST injection. Ruminal fluid ammonia N concentration was lower (P < .01) for TC than for UC before feeding (6.6 vs 7.5 mg/dL) and 4 h later (8.2 vs 12.2 mg/dL), and total VFA concentration was lower (P < .01) for TC than for UC. Treatment with bST decreased (P = .08) DMI with UC (1.15 vs .91 kg/d) and increased (P = .08) DMI with TC (.95 vs 1.06 kg/d). Formaldehyde treatment of casein increased ADG (65, 74, 55, and 91 g/d; P = .03) and clean fleece production (P < .01; 14.1, 17.3, 15.0, and 18.4 g/d for UC-Control, TC-Control, UC-bST, and TC-bST, respectively), with no effect of bST during the 8-wk period of treatment or for the 8 wk thereafter (P > .10). In conclusion, with yearling Angora wethers, bST does not seem useful to enhance mohair production and may not alter effects of dietary level of ruminally undegradable protein on mohair production.     

Comparative macroanatomic investigations on the formation of the external iliac vein in akkaraman sheep and Angora goat

To evaluate the formation of the external iliac vein in Akkaraman sheep and Angora goats, 8 adult healthy Akkaraman sheep and 8 Angora goats of both sexes, 3 to 4 years of age, were examined. The external iliac vein was formed by the deep femoral and femoral veins in 6 Akkaraman sheep and 7 Angora goats and by the medial circumflex femoral and femoral veins in 2 Akkaraman sheep and I Angora goat. Results from this study are thought to throw light on the future studies on the venous system, and to contribute considerably to the present anatomical knowledge concerning the external iliac vein of sheep and goats.     

Effects of estrone infusion on secretion of F series prostaglandins and on function of the corpus luteum during late gestation in cattle

Catheters were surgically implanted in the carotid artery, jugular vein, and middle uterine vein of 8 cows at 245 days of gestation. Four cows were given 4 mg of estrone/hour via continuous jugular infusion from 0800 hours on day 246 of gestation through 0800 hours on day 250 of gestation; the remaining 4 cows (controls) were given the vehicle for estrone at 10 ml/hour for the same period. Blood samples were collected from the carotid artery every 3 hours during the infusion. Samples were collected hourly from the middle uterine vein from 0 through 8, 54 through 66, and 112 through 120 hours of the infusion periods. After completion of the infusion, corpora lutea were enucleated and blood samples were collected from the carotid artery and uterine vein at hourly intervals for an additional 8 hours. Dispersed cell preparations of the corpora lutea were incubated with and without luteinizing hormone (LH) or dibutyryl cyclic adenosine monophosphate (dbcAMP). Circulating concentrations of unconjugated and conjugated estrone and estradiol-17 beta were higher (P less than 0.05) in the group infused with estrone than in the vehicle-infused group. Mean and base-line concentrations of F series prostaglandins (PGF) for each blood collection period tended to increase (P less than 0.10) during infusion with estrone, but not during infusion with vehicle. After luteectomy, mean and base-line concentrations of PGF also tended (P less than 0.10) to be greater in the estrone-infused cows than in the control cows, but a surge in PGF concentrations due to removal of the ovarian source of progesterone did not develop.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of bovine somatotropin and thyroid hormone status on hormone levels, body weight gain, and mohair fiber growth of Angora goats.

Forty-eight Angora goats (24 wethers and 24 doelings; 5 mo old; 16 +/- 0.5 kg initial BW) were used in an experiment with a 2 x 3 factorial treatment arrangement (n = 8) to evaluate effects of recombinant bovine somatotropin (bST) administration and thyroid hormone status (euthyroid, hypothyroid, and hyperthyroid) on hormone levels, ADG, and mohair fiber growth. The bST was a slow-release zinc-based suspension, with sustained delivery (100 microg/[kg BW x d]) over a 14-d period. Hyperthyroidism was maintained by daily treatment with thyroxine (T4; 150 microg/[kg BW x d]), and hypothyroidism was achieved by feeding 6 mg/(kg BW x d) of propylthiouracil. The experiment was conducted in July to September and consisted of a 2-wk pretreatment period and 8 wk of bST treatment. Goats were given ad libitum access to a diet with 15% CP and 2.54 Mcal/ kg ME (DM basis). Concentrations of T4 and T3 were greatest (P < 0.01) among treatments for hyperthyroid-bST and hyperthyroid-control (T4: 38.6 and 38.0 microg/dL; T3: 406 and 385 ng/dL, respectively); similar among euthyroid-control, euthyroid-bST, and hypothyroid-bST (T4: 11.1, 11.5, and 9.8 microg/dL, respectively; T3: 232, 252, and 226 ng/dL, respectively); and lowest (P < 0.01) for hypothyroid-control (T4: 5.1 microg/dL; T3: 144 ng/dL). Plasma concentration of insulin-like growth factor-I was greatest (P < 0.01) for euthyroid-bST (596 ng/mL) and hypothyroid-bST (618 ng/mL); however, concentration for hyperthyroid-bST was similar to those for euthyroid-control, hypothyroid-control, and hyperthyroid-control (188, 178, 187, and 191 ng/mL, respectively). Dry matter intake was greatest (P < 0.05) for euthyroid-bST (794 g/d), similar among hypothyroid treatments (693 and 703 g/d for control and bST, respectively) and euthyroid-control (681 g/d), and lowest for hyperthyroid groups (554 and 518 g/d for control and bST, respectively); ADG for hyperthyroid goats (11 g/d) was lower than with hypothyroidism and euthyroidism (72 and 73 g/d, respectively); and mohair fiber growth was greater (P < 0.01) for hyperthyroidism (0.133 g/[100 cm2 x d]) than for hypothyroid and euthyroid goats (0.102 and 0.104 g/[100 cm2 x d], respectively). Hyperthyroidism also increased mohair length growth rate by 15% and decreased fiber diameter by 7.8% (P < 0.01). These results demonstrate interactions between growth hormone administration and thyroid hormone status, although these influences had limited effects on ADG and mohair fiber growth.     

Lack of peripheral sympathetic control of uterine blood flow during acute heat stress

Peripheral alpha- and beta-adrenergic control of uterine blood flow (UBF) during acute heat stress of the gravid ewe was investigated. An electromagnetic blood flow probe was surgically implanted around the left miduterine artery and catheters inserted in the left carotid artery and right jugular vein in ewes between d 120 and 130 of gestation. Four or more days postsurgery, ewes were fitted with instruments to measure rectal temperature (Tr), heart rate (HR), respiratory rate (RR), blood pressure (BP) and UBF. One-half hour after instrument calibration, a 15-min thermoneutral control period was initiated with carotid artery blood samples taken at 5-min intervals for pH and PCO2 determinations. Ewes were then subjected to a heat challenge that reached 40 C at 2 h. All physiological data were recorded every 5 min as 1-min mean values. In seven experiments on five ewes, an alpha-adrenergic blocking drug, phenoxybenzamine (PB) was infused at 1 mg/min for 15 min subsequent to maximum depression of UBF. A beta-adrenergic blocking drug, propranolol (PR) was infused at .35 mg/min for 15 min in eight experiments on five ewes. Analysis of variance comparisons were made between the control period and heat stress infusion periods within the PB and PR experiments. Further comparisons were made between the start and 5, 10 or 15 min of PB or PR infusion in order to test drug effects during an acute heat stress. Rectal temperature HR, RR and arterial pH were higher (P less than .05) at the start of PR and PB infusions than during the thermoneutral control period.(ABSTRACT TRUNCATED AT 250 WORDS)     

Effects of propionate infusion and dietary energy on dry matter intake in sheep

Four nonlactating, nonpregnant, mature ewes equipped with multiple venous and arterial catheters were used to evaluate the influence of propionate as a satiety signal in ruminants. Our experiment was a 4 x 4 Latin square with portal infusion (physiological saline [Sa] or sodium propionate [Pr]) and DE intake (Lo, 63% of maintenance requirement, or Hi, 200% of maintenance requirement) as factors. One 240-min infusion of Pr (1 mmol/min) or Sa into the portal vein began at approximately 0800 on d 8 of each 8-d period. Feed intake was measured and hepatic blood was sampled every 30 min during infusion. Intake of DM and digestible energy (DEI) during infusion were not affected by infusion or diet and were most rapid at 30 min postfeeding. Average 30-min DMI and DEI were 539 g and 1,484 kcal, respectively, at 240 min. Cumulative DMI and DEI were unaffected by infusion but tended to be greater with Lo. After 30 min, animals tended to consume Lo at a greater rate than Hi, suggesting that satiety was delayed. Insulin concentration was increased (P less than .02) when animals consumed Hi (36.1 mU/liter) vs Lo (16.8 mU/liter) and was elevated (P less than .01) at 30 and 60 min postfeeding when animals were infused with Pr. Plasma acetate tended to be reduced with Pr infusion. Plasma Pr tended to increase with Pr infusion, especially when sheep were fed Lo. Satiety, DMI, and DEI were not affected by Pr infusion in this study.     

Local effect of progesterone infusion into ovarian artery on activin A and inhibin alpha-subunit secretion during the middle luteal phase in gilts

The present study was undertaken to elucidate whether an increased, but physiological, amount of progesterone (P4) supplied to the porcine corpus luteum affects luteal secretion of activin A and inhibin alpha-subunit (Inhalpha) in freely moving gilts. On day 9 of the estrous cycle (EC), both ovarian arteries and both ovarian veins of gilts (n = 5) were cannulated. Progesterone was infused into the right ovarian arteries in gilts on days 10, 11 and 12 of the EC at a rate adequate to its physiological retrograde transfer found during the middle luteal phase of the EC. The P4 infusion rate was 0.62 microg/min (day 10), 2 x 0.62 microg/min (day 11) and 3 x 0.62 microg/min (day 12). The left ovarian arteries were infused with saline (control). Blood samples were collected from both ovarian veins on days 10-12 of the EC before and after P4 or saline infusion. The mean plasma activin A level in the ovarian vein ipsilateral to the P4-infused ovary was higher (P < 0.0001) on days 10-12 of the EC than this found in the contralateral ovarian vein. The level of activin A in the ovarian vein ipsilataral to the infusion of P4 was higher on days 11 (P < 0.01) and 12 (P < 0.0001) and tended to be higher (P < 0.07) on day 10 of the EC than this in contralateral ovarian vein. The level of Inhalpha in the ovarian vein ipsilateral to the P4-infused ovary on days 10-12 of the EC was not significantly different (P > 0.05) than this found in the contralateral ovarian vein. The results of the present study indicate that a local elevation of P4 concentration in blood supplying the ovary during the middle luteal phase of the porcine EC affects ovarian secretion of activin A. The effect of P4 on the secretion of activin A suggested the existence of a short regulatory loop of a positive feedback between P4 being retrogradely transferred into the ovary and the secretion of this peptide.